Lubris BioPharma Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Lubris BioPharma General Information

Description

Operator of a biopharmaceutical company intended to offer treatment of a wide variety of age and inflammation-related conditions of health. The company offers an endogenous complex glycoprotein that binds to and protects tissue surfaces from friction-induced wear and damage and helps in the treatment of surgical adhesions, xerostomia, pericarditis, and other conditions, enabling doctors to offer improved treatment for dry eye disease.

Contact Information

Website
www.lubris.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 85 Nobscot Road
  • Weston, MA 02493
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lubris BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 15-Mar-2017 000 Completed Clinical Trials - Phase 2
5. Later Stage VC 000 Completed Clinical Trials - Phase 2
4. Early Stage VC (Series A) 01-Jul-2015 000 Completed Clinical Trials - Phase 2
3. Accelerator/Incubator 22-Sep-2014 000 Completed Pre-Clinical Trials
2. Seed Round 15-Mar-2013 $4M $4M 0000 Completed Startup
1. Spin-Off 01-Jan-2011 Completed Startup
To view Lubris BioPharma’s complete valuation and funding history, request access »

Lubris BioPharma Patents

Lubris BioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3976085-A4 Use of prg4 to treat cancer Inactive 03-Jun-2019 000000000 0
EP-3976085-A1 Use of prg4 to treat cancer Inactive 03-Jun-2019 00000000000
US-20220332839-A1 Use of prg4 to treat cancer Pending 03-Jun-2019 000000000
AU-2019290206-A1 Lubricin for use in wound healing Inactive 21-Jun-2018 000000000
US-20210260167-A1 Lubricin for use in wound healing Inactive 21-Jun-2018 A61K38/39
To view Lubris BioPharma’s complete patent history, request access »

Lubris BioPharma Executive Team (7)

Name Title Board Seat Contact Info
Edward Truitt JD Co-Founder & Chief Executive Officer
Tannin Schmidt Ph.D Co-Founder & Senior Scientific Consultant
Gregory Jay Ph.D Co-Founder & Senior Medical Advisor
David Sullivan Ph.D Co-Founder & Senior Scientific Advisor
Harry Barnett JD Co-Founder & Executive Chairman
You’re viewing 5 of 7 executive team members. Get the full list »

Lubris BioPharma Board Members (3)

Name Representing Role Since
Benjamin Sullivan Ph.D Lubris BioPharma Co-Founder, Scientific Advisor & Board Member 000 0000
Edmund Pitcher JD Lubris BioPharma Co-Founder & Board Member 000 0000
Harry Barnett JD Lubris BioPharma Co-Founder & Executive Chairman 000 0000
To view Lubris BioPharma’s complete board members history, request access »

Lubris BioPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lubris BioPharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tarnagulla Ventures Venture Capital Minority 000 0000 000000 0
CONNECT (Accelerator) Accelerator/Incubator 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
SeedFolio Venture Capital Minority 000 0000 000000 0
To view Lubris BioPharma’s complete investors history, request access »

Lubris BioPharma FAQs

  • When was Lubris BioPharma founded?

    Lubris BioPharma was founded in 2011.

  • Who is the founder of Lubris BioPharma?

    Edward Truitt JD, Tannin Schmidt Ph.D, Gregory Jay Ph.D, David Sullivan Ph.D, Harry Barnett JD, Edmund Pitcher JD, and Benjamin Sullivan Ph.D are the founders of Lubris BioPharma.

  • Who is the CEO of Lubris BioPharma?

    Edward Truitt JD is the CEO of Lubris BioPharma.

  • Where is Lubris BioPharma headquartered?

    Lubris BioPharma is headquartered in Weston, MA.

  • What is the size of Lubris BioPharma?

    Lubris BioPharma has 4 total employees.

  • What industry is Lubris BioPharma in?

    Lubris BioPharma’s primary industry is Biotechnology.

  • Is Lubris BioPharma a private or public company?

    Lubris BioPharma is a Private company.

  • What is Lubris BioPharma’s current revenue?

    The current revenue for Lubris BioPharma is 000000.

  • How much funding has Lubris BioPharma raised over time?

    Lubris BioPharma has raised $4M.

  • Who are Lubris BioPharma’s investors?

    Tarnagulla Ventures, CONNECT (Accelerator), Johnson & Johnson Innovation - JLABS, and SeedFolio have invested in Lubris BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »